Log in

LIFS Life Stem Genetics Inc. OTC · United States

Life Stem Genetics (LIFS) news

Life Stem Genetics Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker LIFS, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Life Stem Genetics news

We have not published a story on Life Stem Genetics yet. When there is news, it will appear here.

Questions about Life Stem Genetics

What is the ticker symbol of Life Stem Genetics?

Life Stem Genetics Inc. trades under the ticker LIFS on OTC.

Where is Life Stem Genetics listed?

Life Stem Genetics Inc. is listed on OTC.

Which country or territory is Life Stem Genetics listed under?

Our directory records Life Stem Genetics Inc. under United States.

What does Life Stem Genetics do?

Our directory classifies Life Stem Genetics Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Life Stem Genetics?

The ISIN recorded for Life Stem Genetics Inc. is US53217Y1038.

Does aibio.space cover Life Stem Genetics?

aibio.space lists Life Stem Genetics Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Life Stem Genetics?

Companies in our directory listed in the same country and business area as Life Stem Genetics: United Therapeutics, DiaMedica Therapeutics, Natera, Foghorn Therapeutics, Zentalis Pharmaceuticals, Cadrenal Therapeutics.

Investor discussion: Life Stem Genetics

Members talk about Life Stem Genetics (LIFS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:LIFS on TradingView.

Listing details

Life Stem Genetics Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker LIFS, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Life Stem Genetics Inc.
Ticker
LIFS
Listing
OTC
Country or territory
United States
Business scope
Biotechnology
ISIN
US53217Y1038
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.